These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 21602815)
1. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815 [TBL] [Abstract][Full Text] [Related]
2. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene]. Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350 [TBL] [Abstract][Full Text] [Related]
3. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276 [TBL] [Abstract][Full Text] [Related]
5. VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma. Lessi F; Mazzanti CM; Tomei S; Di Cristofano C; Minervini A; Menicagli M; Apollo A; Masieri L; Collecchi P; Minervini R; Carini M; Bevilacqua G Med Oncol; 2014 Mar; 31(3):840. PubMed ID: 24446253 [TBL] [Abstract][Full Text] [Related]
6. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity. Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity. Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809 [TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362 [TBL] [Abstract][Full Text] [Related]
10. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463 [TBL] [Abstract][Full Text] [Related]
11. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma. Gong K; Zhang N; Zhang K; Na Y Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786 [TBL] [Abstract][Full Text] [Related]
12. von Hippel-Lindau disease-related neoplasia with an emphasis on renal manifestations. Tekin B; Erickson LA; Gupta S Semin Diagn Pathol; 2024 Jan; 41(1):20-27. PubMed ID: 37980175 [TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma. Damjanovic SS; Ilic BB; Beleslin Cokic BB; Antic JA; Bankovic JZ; Milicevic IT; Rodic GS; Ilic DS; Todorovic VN; Puskas N; Tulic CD Exp Mol Pathol; 2016 Dec; 101(3):323-331. PubMed ID: 27845047 [TBL] [Abstract][Full Text] [Related]
14. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation. He Z; Liu S; Guo M; Mao J; Hughson MD Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424 [TBL] [Abstract][Full Text] [Related]
15. Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review. Hes O; Compérat EM; Rioux-Leclercq N Ann Diagn Pathol; 2016 Apr; 21():59-64. PubMed ID: 26897641 [TBL] [Abstract][Full Text] [Related]
17. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836 [TBL] [Abstract][Full Text] [Related]
18. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene. Hughson MD; He Z; Liu S; Coleman J; Shingleton WB Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers]. Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583 [TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]